{"transactions":[{"id":838653,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":60094,"kind":"person","name":"Biddle Warner Weston","position":1,"cik":"0002034523","reported_name":"Biddle Warner Weston","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-17T16:30:12.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the option shall vest on March 13, 2027 and an additional 1/48th of the shares subject to the option shall vest on the same day of each month thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":350000,"derivative":{"exercise_price":8.95,"expiration_date":"2036-03-13","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001193125-26-110920","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034523/000119312526110920/ownership.xml","form_type":"4"}},{"id":838652,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":60094,"kind":"person","name":"Biddle Warner Weston","position":1,"cik":"0002034523","reported_name":"Biddle Warner Weston","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-17T16:30:12.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":58000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award of common stock and 1/4th of the shares underlying the restricted stock unit award shall vest on March 13, 2027 and an additional 1/4th of the shares underlying the restricted stock unit award shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":58000,"source":{"system":"sec-edgar","filing":"0001193125-26-110920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034523/000119312526110920/ownership.xml","form_type":"4"}},{"id":1171946,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":60094,"kind":"person","name":"Biddle Warner Weston","position":1,"cik":"0002034523","reported_name":"Biddle Warner Weston","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-15T17:42:51.000Z","date":"2024-04-11","kind":"grant","planned":false,"acquired":true,"shares":332500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on April 11, 2026, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":332500,"derivative":{"exercise_price":2.06,"expiration_date":"2035-04-11","underlying":"Common Stock","underlying_shares":332500},"source":{"system":"sec-edgar","filing":"0000950170-25-054345","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034523/000095017025054345/ownership.xml","form_type":"4"}},{"id":1403904,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":60094,"kind":"person","name":"Biddle Warner Weston","position":1,"cik":"0002034523","reported_name":"Biddle Warner Weston","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T21:18:53.000Z","date":"2024-09-16","kind":"grant","planned":false,"acquired":true,"shares":2579259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on September 16, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":2579259,"derivative":{"exercise_price":6.89,"expiration_date":"2034-09-16","underlying":"Common Stock","underlying_shares":2579259},"source":{"system":"sec-edgar","filing":"0000950170-24-107968","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034523/000095017024107968/ownership.xml","form_type":"4"}}]}